We are live on ! Find out more
HP

Hikari Power Portfolio holdings

AUM $855M
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+14.24%
3 Year Est. Return
+53.45%
5 Year Est. Return
+75.51%
10 Year Est. Return
+220.8%
AUM
$927M
AUM Growth
-$1.43M
Cap. Flow
+$7.24M
Cap. Flow %
0.78%
Top 10 Hldgs %
60.5%
Holding
125
New
10
Increased
26
Reduced
9
Closed
9

Top Buys

Rank Stock Value
1
SPTS icon
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
+$11.3M
2
WFC icon
Wells Fargo
WFC
+$9.14M
3
XOM icon
ExxonMobil
XOM
+$3.7M
4
MMM icon
3M
MMM
+$2.2M
5
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
+$2.09M

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$9.37M
2
WAB icon
Wabtec
WAB
+$5.68M
3
PG icon
Procter & Gamble
PG
+$4.97M
4
GIS icon
General Mills
GIS
+$3.54M
5
CELG
Celgene Corp
CELG
+$3.18M

Sector Composition

Rank Sector Weight
1 Financials 39.92%
2 Healthcare 20.04%
3 Industrials 8.62%
4 Materials 5.03%
5 Technology 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRRA
101
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$195K 0.02%
12,503
+6,200
+98% +$119K
TGNA
102
DELISTED
TEGNA Inc
TGNA
$189K 0.02%
12,180
– –
EAF icon
103
GrafTech
EAF
$206M
$181K 0.02%
1,415
– –
SPHS
104
DELISTED
Sophiris Bio, Inc.
SPHS
$176K 0.02%
300,900
– –
CALA
105
DELISTED
Calithera Biosciences, Inc
CALA
$155K 0.02%
2,500
– –
MDR
106
DELISTED
McDermott International
MDR
$153K 0.02%
75,600
– –
INVA icon
107
Innoviva
INVA
$1.5B
$151K 0.02%
14,340
– –
MIK
108
DELISTED
Michaels Stores, Inc
MIK
$151K 0.02%
15,450
– –
LRMR icon
109
Larimar Therapeutics
LRMR
$448M
$148K 0.02%
16,718
+4,175
+33% +$45.8K
MRSN
110
DELISTED
Mersana Therapeutics
MRSN
$143K 0.02%
3,610
– –
GME icon
111
GameStop
GME
$8.44B
$122K 0.01%
88,480
– –
FTSI
112
DELISTED
FTS International, Inc. Common Stock
FTSI
$42K ﹤0.01%
932
– –
ACAD icon
113
Acadia Pharmaceuticals
ACAD
$5.07B
– –
-18,535
Closed -$495K
HPQ icon
114
HP
HPQ
$26.6B
– –
-9,790
Closed -$204K
HRB icon
115
H&R Block
HRB
$5.92B
– –
-7,590
Closed -$222K
MAN icon
116
ManpowerGroup
MAN
$2.62B
– –
-2,300
Closed -$222K
NKTR icon
117
Nektar Therapeutics
NKTR
$2.55B
– –
-393
Closed -$210K
VKTX icon
118
Viking Therapeutics
VKTX
$3.94B
– –
-50,000
Closed -$415K
KA
119
DELISTED
Kineta, Inc. Common Stock
KA
– –
-167
Closed -$23K
MTOR
120
DELISTED
MERITOR, Inc.
MTOR
– –
-8,470
Closed -$205K
1 2 3 4
5

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Hikari Power's Q3 2019 Portfolio in Review

As of Q3 2019, Hikari Power held 125 positions worth $927M, down 0.15% from $928M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Hikari Power's Q3 2019 filing shows 10 new, 26 increased, 9 reduced and 9 closed positions. Its largest new stake was State Street SPDR Portfolio Short Term Treasury ETF: 376,500 shares worth $11.3M. The largest sale was Colgate-Palmolive, an estimated $9.37M.

By sector, the portfolio is most concentrated in Financials at 40% of assets, up from 38% a quarter earlier, followed by Healthcare and Industrials.

  • Hikari Power's largest Q3 2019 buy was State Street SPDR Portfolio Short Term Treasury ETF: 376,500 shares worth $11.3M.
  • Hikari Power added most to Wells Fargo in Q3 2019, an estimated $9.14M increase.
  • Hikari Power's biggest Q3 2019 reduction was Colgate-Palmolive, cutting an estimated $9.37M.
  • Hikari Power fully exited Acadia Pharmaceuticals in Q3 2019, selling an estimated $495K.
  • Hikari Power's ten largest holdings make up 61% of its $927M portfolio in Q3 2019.
  • Hikari Power opened 10 new positions and closed 9 in Q3 2019.
  • Hikari Power's portfolio value fell 0.15% quarter-over-quarter to $927M.

Based on Hikari Power's 13F filing for Q3 2019, filed 31 Oct 2019.